These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2389694)

  • 1. Comparison of hypersensitivity to adrenergic stimulation after abrupt withdrawal of propranolol and nadolol: influence of half-life differences.
    Krukemyer JJ; Boudoulas H; Binkley PF; Lima JJ
    Am Heart J; 1990 Sep; 120(3):572-9. PubMed ID: 2389694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockade disappearance rate predicts beta-adrenergic hypersensitivity.
    Reeves RA; Boer WH; DeLeve L; Leenen FH
    Clin Pharmacol Ther; 1989 Sep; 46(3):279-90. PubMed ID: 2550167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs.
    Webb JG; Newman WH; Walle T; Daniell HB
    J Cardiovasc Pharmacol; 1981; 3(3):622-35. PubMed ID: 6168842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of withdrawal phenomena after propranolol, metoprolol, and pindolol.
    Rangno RE; Langlois S
    Am Heart J; 1982 Aug; 104(2 Pt 2):473-8. PubMed ID: 7102534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phenomenon of beta-adrenergic hypersensitivity following propranolol withdrawal studied in normal subjects.
    Kiyingi KS; Shaw J
    Eur J Clin Pharmacol; 1984; 27(4):423-8. PubMed ID: 6097455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects.
    Boudoulas H; Lewis RP; Kates RE; Dalamangas G
    Ann Intern Med; 1977 Oct; 87(4):433-6. PubMed ID: 199099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic rebound phenomena after abrupt cessation of propranolol therapy in portal hypertensive rats.
    Lee SS; Braillon A; Girod C; Geoffroy P; Lebrec D
    J Hepatol; 1986; 3(1):38-41. PubMed ID: 3018073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of cyclic AMP concentration to isoproterenol after abrupt cessation of propranolol in rats.
    Kobayashi A; Ogawa K; Yamazaki N
    Jpn Heart J; 1980 May; 21(3):399-407. PubMed ID: 6249944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy.
    Gilligan DM; Chan WL; Stewart R; Oakley CM
    Am J Cardiol; 1991 Sep; 68(8):766-72. PubMed ID: 1892084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of propranolol withdrawal phenomena.
    Nattel S; Rangno RE; Van Loon G
    Circulation; 1979 Jun; 59(6):1158-64. PubMed ID: 436208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic pattern of hypersensitivity following acute propranolol withdrawal in normal subjects.
    Krukemyer JJ; Boudoulas H; Binkley PF; Lima JJ
    Life Sci; 1989; 45(17):1547-51. PubMed ID: 2586219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol withdrawal-induced supersensitivity to the chronotropic effects of isoproterenol in the conscious rabbit.
    Tenner TE
    Life Sci; 1983 Dec; 33(23):2291-9. PubMed ID: 6685807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
    Duchin KL; Stern MA; Willard DA; McKinstry DN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule.
    Rangno RE; Nattel S; Lutterodt A
    Am J Cardiol; 1982 Mar; 49(4):828-33. PubMed ID: 6278914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
    Schiffelers SL; Blaak EE; Saris WH; van Baak MA
    Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of equiblocking doses of nadolol and propranolol on left ventricular performance.
    Le Winter MM; Curtis GP; Engler RL; Shabetai R; Verba J
    Clin Pharmacol Ther; 1979 Aug; 26(2):162-6. PubMed ID: 37012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.
    Rangno RE; Langlois S
    Br J Clin Pharmacol; 1982; 13(Suppl 2):345S-351S. PubMed ID: 6125187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The comparative results of a short course of nadolol and propranolol treatment of arterial hypertension patients (cooperative research). The Working Group of the Cooperative Program for the Study of New Preparations in Preventing Arterial Hypertension].
    Ter Arkh; 1989; 61(12):30-6. PubMed ID: 2697955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker duration of action and implications for therapy.
    Kostis JB
    Am J Cardiol; 1990 Nov; 66(16):60G-62G. PubMed ID: 1978546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.